ArticleInternational journal of cardiology2025

Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.

Yu Horiuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.